Organization · Venture Capital
OMX Ventures
OMX Ventures is an early-stage venture capital firm based in Lincolnshire, Illinois, focusing on biotech and life sciences. The firm employs a technology-first approach to transform innovative discoveries into scalable companies.
Overview
What OMX Ventures does
What OMX Ventures is
OMX Ventures is an early-stage venture capital firm based in Lincolnshire, Illinois, focusing on biotech and life sciences. The firm employs a technology-first approach to transform innovative discoveries into scalable companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find OMX Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
OMX Ventures as a funder
Investment thesis
OMX Ventures employs a technology-first approach to invest in transformative biotech technologies that address unmet needs in large markets, focusing on the convergence of biology, big data, and AI.
Focus narrative
OMX Ventures specializes in Seed and Series A funding, targeting transformative technologies in the biotech sector. The firm invests across the U.S., UK, and Europe, focusing on innovations that address unmet needs in large markets, particularly in therapeutics, bio-tools, diagnostics, and synthetic biology.
Value beyond capital
OMX Ventures adds value to its portfolio companies through a technology-first approach, leveraging expertise in biology, big data, and AI to support company creation alongside investment. The firm provides strategic guidance, industry connections, and resources to help portfolio companies scale and succeed in the competitive biotech landscape.
Focus and fit
- Stages
- Seed · Series A
- Sectors
- Biotech · Healthcare · Diagnostics · Synthetic Biology
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: Delix Therapeutics: Developing non-hallucinogenic psychedelic compounds for psychiatric and neurological indications. Freya Biosciences: Focused on restoring healthy vaginal microbiomes to improve in-vitro fertilization efficacy. Constructive Bio: Pioneering synthetic genome writing and engineered translation technologies. Matterworks: Building machine-learning software for metabolomics analysis. VedaBio: Innovating molecular biology with a platform for near-instant detection of multiplexed analytes. Glyphic Biotechnologies: Developing a next-generation proteomics platform for protein sequencing.
Common questions
What to know about OMX Ventures
Upseed classifies OMX Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.